Scientists have identified the specific genetic changes that caused a particularly severe outbreak of meningitis in Kent earlier this year.
Researchers from the UK Health Security Agency (UKHSA) and the University of Oxford used advanced bacterial genome sequencing to determine why a cluster of cases in March 2026 led to such high rates of serious illness. The findings, presented at the UKHSA Conference 2026 on 22 September, revealed that the bacteria responsible had “stolen” DNA from harmless bacteria usually found in the human throat.
The process, known as horizontal gene transfer, allowed the MenB (meningococcal group B) bacteria to acquire genetic material that made it significantly more invasive. While this change made the strain more dangerous to those who caught it, scientists noted a potential “trade-off” where the bacteria became less effective at living harmlessly in the throat, which may have limited its wider spread through the population.
The Kent outbreak
The outbreak in March 2026 was linked to a nightclub in Canterbury and involved 21 confirmed cases of invasive meningococcal disease (IMD). The severity of the strain was evident in the clinical outcomes; nine of the 21 patients required intensive care treatment.
Tragically, two people died during the outbreak: a Year 13 school pupil and a 21-year-old university student.
Dr Charlene Rodrigues, a consultant in pathogen genomics at UKHSA who led the investigation, explained that every culture-confirmed case of IMD in England has been routinely whole-genome sequenced since 2010. This surveillance allowed scientists to rapidly identify the unusual variant and track its progression.
Changes to national vaccination policy
The severity of the Kent cases has reinforced recent shifts in national health policy. Looking further ahead, the Joint Committee on Vaccination and Immunisation (JCVI) has recommended that the MenB vaccine be added to the routine adolescent immunisation schedule. This is expected to be offered to teenagers around the age of 15, with the programme scheduled to begin in 2030.
According to official UKHSA guidance, while invasive strains of meningitis are unpredictable, genomic surveillance remains a critical tool in detecting and responding to unusual variants before they can spread further.
Signs and symptoms
Health officials continue to urge the public to be aware of the symptoms of meningitis and septicaemia, as early treatment is vital. Key signs include:
- A high fever with cold hands and feet
- Severe headache and a stiff neck
- Confusion or irritability
- Sensitivity to bright lights
- A rash that does not fade when a glass is pressed firmly against it (though this may not appear in all cases)
Anyone who suspects meningitis should seek emergency medical help immediately by calling 999 or attending the nearest A&E department.
